Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Acyl CoA cholesterol O acyltransferase"'
Autor:
Noriko Noguchi, Yasuomi Urano, Masayoshi Miyamoto, Yoshihiko Tsunenari, Shin-ichiro Ogawa, Kimiyuki Shibuya, Shigeru Morikawa
Publikováno v:
ACS Omega
ACS Omega, Vol 4, Iss 16, Pp 16943-16955 (2019)
ACS Omega, Vol 4, Iss 16, Pp 16943-16955 (2019)
An acyl-CoA:cholesterol O-acyltransferase-1 (ACAT-1/SOAT-1) inhibitor, K-604 is a promising drug candidate for the treatment of Alzheimer's disease and glioblastoma; however, it exhibits poor solubility in neutral water and low permeability across th
Autor:
John T. Fallon, Valentin Fuster, Juan J. Badimon, Zahi A. Fayad, Stephen G. Worthley, Gérard Helft, Matthew I. Worthley, Roberto Corti, Derek P. Chew, Azfar Zaman
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 36:9-17
The ability to modify the enzymatic processes involved in promoting atherosclerotic plaque disruption and to serially monitor atherosclerotic evolution could provide novel information in the management of patients with atherosclerosis. We studied the
Autor:
Maureen K. Anderson, Andrew D. White, Thomas M.A. Bocan, R. F. Bousley, Claude Forsey Purchase, Sandra Bak Mueller, Brian R. Krause, Peter Lee, J. F. Reindel, Reynold Homan, R. L. Stanfield, K. L. Hamelehle, Cecilia Speyer
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:1753-1758
A novel series of tetrazole-substituted ureas 2 were prepared from weakly nucleophilic amines using a new coupling method. The ureas were found to potently inhibit liver ACAT in vitro and lower total serum cholesterol in vivo. A comparison of urea 2b
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:2683-2688
Modification and structure-activity relationships of ACAT inhibitor pyripyropene were examined. PR-109 (7g) showed the most potent (IC50 = 6 nM) inhibitory activity. PR-86 (2e) also had strong inhibitory activity (IC50 = 19 nM) and its in vivo activi
Autor:
R. F. Bousley, Brian R. Krause, Helen T. Lee, K. L. Hamelehle, Drago Robert Sliskovic, R. L. Stanfield
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:301-306
The syntheses and biological activities of a series of novel sulfonamide tetrazole derivatives are reported. The ability of these compounds to inhibit ACAT is described. Such agents may decrease the absorption of dietary cholesterol in the intestine
Autor:
Brian R. Krause, M. A. Dominick, M. Neub, Michael W. Wilson, C. J. Blankley, Andrew D. White, A. W. Chucholowski, K. L. Hamelehle, Mark Wallace Creswell, R. F. Bousley, A. D. Essenburg, R. L. Stanfield
Publikováno v:
ChemInform. 28
Autor:
Thomas M.A. Bocan, Patrick Michael O'brien, D. R. Sliskovic, Helen T. Lee, Brian R. Krause, R. L. Stanfield, R. F. Bousley, Peter H.U. Lee, J. A. Picard, Bruce D. Roth, C. F. Ii Purchase, Sandra Bak Mueller, Maureen K. Anderson, J. F. Reindel, D. Turluck, K. L. Hamelehle, Andrew D. White, Reynold Homan
Publikováno v:
ChemInform. 27
Autor:
R. L. Stanfield, Brian R. Krause, K. L. Hamelehle, Cecilia Speyer, Thomas M.A. Bocan, J. F. Reindel, Andrew D. White, R. F. Bousley, Reynold Homan, Sandra Bak Mueller, Maureen K. Anderson, Claude Forsey Purchase, Peter Lee
Publikováno v:
ChemInform. 27
A novel series of tetrazole-substituted ureas 2 were prepared from weakly nucleophilic amines using a new coupling method. The ureas were found to potently inhibit liver ACAT in vitro and lower total serum cholesterol in vivo. A comparison of urea 2b
Autor:
Noriko Ishibe, Hiroyuki Hagihara, Masae Sawada, Akira Tanaka, Hirokazu Tanaka, Takeshi Terasawa, Yuri Sakuma, Takayoshi Kinoshita, Hisashi Takasugi
Publikováno v:
ChemInform. 29
The synthesis, single crystal X-ray structural analysis, and biological activity of FR186054 (2c), a new, potent, orally efficacious inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT), containing a pyrazole ring are described. This compound d
Autor:
Brian R. Krause, Bruce D. Roth, R. L. Stanfield, R. F. Bousley, K. L. Hamelehle, Helen T. Lee, W. H. Roark, Joseph Armand Picard, Drago Robert Sliskovic
Publikováno v:
ChemInform. 29
Sulfoacetic acid, phosphoramidate, and phosphonamide analogs of the ACAT inhibitors, CI-999 and CI-1011 were synthesized. The structure-activity relationships of these compounds as ACAT inhibitors are described.